CTOs on the Move

Flow Blockchain

www.onflow.org

 
Flow is a fast, secure, and developer-friendly blockchain built to support the next generation of games, apps, and the digital assets that power them.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Flow Blockchain raised $18M on 10/10/2020

Similar Companies

Infovity

At Infovity, we’re proud to be an Oracle focused implementation team. Our innovative and affordable pre-built, repeatable models accelerate Oracle Cloud implementations and integrations.

Falkonry

Falkony helps companies improve the performance, throughput, quality and yield of their industrial operations. We do this by discovering patterns hidden in your existing operational data and delivering actionable analytical insights.

Restaurant365

Restaurant365 is a cloud-based all-inclusive back office solution that combines key restaurant modules with an integrated accounting backbone. Restaurant365 was founded by an experienced team of software veterans committed to developing an accounting, back office, and reporting tool - specifically for restaurants - that scales and positions restaurant concepts for growth. The platform is mobile and runs on both PC and Mac. The connectors, import functions, and Open APIs truly enable Restaurant365 to talk​ with other systems including POS providers, payroll processors, vendors, and banks. Restaurant365 recently closed $88 million in Series C funding, bringing the total minority investment by Bessemer Venture Partners, ICONIQ Capital, and Tiger Global Management to $140 million, to support the company`s vision of providing the best technology to the restaurant industry. With offices in Irvine, CA, and Austin, TX, Restaurant365 truly ties the restaurant industry together with complete restaurant management software.

Heizenrader

Revolutionizing Education with Immersive #MixedReality

Carmot Therapeutics

Carmot Therapeutics is a drug discovery and development company that uses Chemotype Evolution to target the root causes that drive cancer and metabolic diseases.